NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

MakeMyTrip Considers Alternative Listing Route for Indian Arm

MakeMyTrip, a Nasdaq-listed travel company, is exploring the option of listing its Indian arm via Indian Depository Receipts (IDRs) instead of a traditional initial public offering (IPO), according to sources close to the matter.

The company's decision to consider IDRs comes as it seeks to tap into the growing Indian market. IDRs allow foreign companies to list their shares on Indian stock exchanges, providing them with access to a large and growing pool of investors. In contrast, an IPO would require MakeMyTrip to comply with Indian listing regulations, which could be a more complex and time-consuming process.

The Indian arm of MakeMyTrip has been growing rapidly in recent years, with the company's revenues in the region increasing significantly. In 2022, the company's Indian arm reported revenues of $800 million, up from $500 million in 2021. The growth of the Indian arm has made it an attractive candidate for listing, with investors looking to tap into the country's rapidly expanding middle class.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Listing MethodRevenues (2022)Revenues (2021)Growth Rate
IDRs$800 million$500 million60%
IPO$800 million$500 million60%

As MakeMyTrip continues to explore its options, the company is likely to face intense scrutiny from investors and regulators. The decision to list its Indian arm via IDRs or IPO will have significant implications for the company's growth prospects and its ability to tap into the Indian market.

Investor Takeaway

Consider the potential benefits of listing through Depository Receipts.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.